CSPC Pharma ramps up USD/RMB hedging with FX swap, forwards totaling USD 344 million

PUBT · 2d ago
CSPC Pharma ramps up USD/RMB hedging with FX swap, forwards totaling USD 344 million
  • CSPC Pharmaceutical set a plan to actively manage USD/RMB exposure via FX hedging in its treasury activities.
  • Strategy uses an FX Swap Contract, locking USD 134 million against RMB 905.41 million through Sept. 16, 2026.
  • Two FX Forward Contracts add planned USD purchases of USD 210 million for RMB 1.43 billion, settling Nov. 25, 2026, and Dec. 18, 2026.
  • Initial security deposits total USD 10.06 million, with potential margin top-ups if floating losses reach 80% of posted collateral.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSPC Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260730-12262265), on July 30, 2026, and is solely responsible for the information contained therein.